These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 20220589

  • 1. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
    Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, DIADS-2 Research Group.
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):332-40. PubMed ID: 20220589
    [Abstract] [Full Text] [Related]

  • 2. Sertraline for the treatment of depression in Alzheimer disease.
    Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, DIADS-2 Research Group.
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):136-45. PubMed ID: 20087081
    [Abstract] [Full Text] [Related]

  • 3. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [Abstract] [Full Text] [Related]

  • 4. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
    Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.
    Lancet; 2011 Jul 30; 378(9789):403-11. PubMed ID: 21764118
    [Abstract] [Full Text] [Related]

  • 5. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
    Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.
    Health Technol Assess; 2013 Feb 30; 17(7):1-166. PubMed ID: 23438937
    [Abstract] [Full Text] [Related]

  • 6. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 30; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 7. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS.
    Hum Psychopharmacol; 2005 Mar 30; 20(2):97-104. PubMed ID: 15641125
    [Abstract] [Full Text] [Related]

  • 8. Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial.
    Zuidersma M, Chua KC, Hellier J, Voshaar RO, Banerjee S, HTA-SADD Investigator Group.
    Am J Geriatr Psychiatry; 2019 Sep 30; 27(9):920-931. PubMed ID: 31084994
    [Abstract] [Full Text] [Related]

  • 9. Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
    Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, DIADS-2 Research Group.
    Am J Geriatr Psychiatry; 2014 Jan 30; 22(1):14-24. PubMed ID: 24314887
    [Abstract] [Full Text] [Related]

  • 10. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
    Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, DIADS-2 Research Group.
    Int J Geriatr Psychiatry; 2011 Jun 30; 26(6):573-83. PubMed ID: 20672243
    [Abstract] [Full Text] [Related]

  • 11. Antidepressants for depression in patients with dementia: a review of the literature.
    Leong C.
    Consult Pharm; 2014 Apr 30; 29(4):254-63. PubMed ID: 24704894
    [Abstract] [Full Text] [Related]

  • 12. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial.
    Bergh S, Selbæk G, Engedal K.
    BMJ; 2012 Mar 09; 344():e1566. PubMed ID: 22408266
    [Abstract] [Full Text] [Related]

  • 13. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders.
    Cummings JL, McRae T, Zhang R, Donepezil-Sertraline Study Group.
    Am J Geriatr Psychiatry; 2006 Jul 09; 14(7):605-12. PubMed ID: 16816014
    [Abstract] [Full Text] [Related]

  • 14. Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study.
    Steinberg M, Munro CA, Samus Q, V Rabins P, Brandt J, Lyketsos CG.
    Int J Geriatr Psychiatry; 2004 Feb 09; 19(2):144-50. PubMed ID: 14758580
    [Abstract] [Full Text] [Related]

  • 15. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR, Wyld D, Abdi EA, Glasgow A, Beale PJ, Jefford M, Dhillon H, Heritier S, Carter C, Hickie IB, Simes RJ, Zoloft's Effects on Symptoms and survival Time Trial Group.
    Lancet Oncol; 2007 Jul 09; 8(7):603-12. PubMed ID: 17548243
    [Abstract] [Full Text] [Related]

  • 16. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH, Lin SH, Jang FL.
    J Clin Psychopharmacol; 2011 Oct 09; 31(5):563-8. PubMed ID: 21869699
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial.
    Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R, Bentham P, Burns A, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Banerjee S.
    Br J Psychiatry; 2013 Feb 09; 202():121-8. PubMed ID: 23258767
    [Abstract] [Full Text] [Related]

  • 18. Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
    Peters ME, Vaidya V, Drye LT, Rosenberg PB, Martin BK, Porsteinsson AP, Frangakis CE, Mintzer J, Weintraub D, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Avramopoulos D, DIADS-2 Research Group.
    J Geriatr Psychiatry Neurol; 2011 Dec 09; 24(4):222-8. PubMed ID: 22228829
    [Abstract] [Full Text] [Related]

  • 19. Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
    Mokhber N, Abdollahian E, Soltanifar A, Samadi R, Saghebi A, Haghighi MB, Azarpazhooh A.
    Pharmacopsychiatry; 2014 Jul 09; 47(4-5):131-40. PubMed ID: 24955552
    [Abstract] [Full Text] [Related]

  • 20. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
    Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, Depression in Alzheimer’s Disease Study–2 Research Group.
    Am J Geriatr Psychiatry; 2012 Dec 09; 20(12):1036-44. PubMed ID: 23032478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.